Home » Stocks » STE

Steris PLC (STE)

Stock Price: $188.76 USD 0.43 (0.23%)
Updated Jan 22, 2021 4:00 PM EST - Market closed
Market Cap 16.13B
Revenue (ttm) 3.02B
Net Income (ttm) 422.29M
Shares Out 85.05M
EPS (ttm) 4.93
PE Ratio 38.29
Forward PE 26.32
Dividend $1.60
Dividend Yield 0.85%
Trading Day January 22
Last Price $188.76
Previous Close $188.33
Change ($) 0.43
Change (%) 0.23%
Day's Open 187.64
Day's Range 186.90 - 189.54
Day's Volume 402,361
52-Week Range 107.01 - 202.81

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 3 days ago

DUBLIN, IRELAND, Jan. 19, 2021 (GLOBE NEWSWIRE) --  STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2021 third quar...

Seeking Alpha - 4 days ago

Steris is a long-term value creator, which combines organic growth with bolt-on acquisitions. The company started 2021 with a big deal, acquiring Cantel in a multi-billion transaction.

Business Wire - 1 week ago

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Cantel M...

Other stocks mentioned: CMD
Zacks Investment Research - 1 week ago

STERIS (STE) expects to strengthen and expand its endoscopy offerings along with extending into a new customer territory via the Cantel Medical buyout.

Other stocks mentioned: CMD
PRNewsWire - 1 week ago

NEW YORK, Jan. 12, 2021 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Cantel Medical Corporation (NYSE: CMD) ("Cantel") and its board of directors con...

Other stocks mentioned: CMD
Market Watch - 1 week ago

Shares of Cantel Medical Corp. rose 1.8% in premarket trading Tuesday, after the infection prevention products company announced an agreement to be acquired by Ireland-based Steris PLC in a ca...

Other stocks mentioned: CMD
GlobeNewsWire - 1 week ago

DUBLIN, IRELAND and LITTLE FALLS, N.J, Jan. 12, 2021 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) and Cantel Medical Corp (NYSE:CMD) (“Cantel”) today announced that S...

GlobeNewsWire - 2 weeks ago

DUBLIN, IRELAND, Jan. 07, 2021 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that the Company will be publicly webcasting presentations made by Walt Ro...

Zacks Investment Research - 1 month ago

Steris (STE) reported earnings 30 days ago. What's next for the stock?

GlobeNewsWire - 2 months ago

DUBLIN, IRELAND, Nov. 18, 2020 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that is has completed the previously announced acquisition of Key Surgical...

Zacks Investment Research - 2 months ago

3 Best Buys from the Prospering Medical Instruments Industry

Other stocks mentioned: IDXX, TMO
Seeking Alpha - 2 months ago

STERIS plc's (STE) CEO Walter Rosebrough on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha - 2 months ago

STERIS plc (STE) CEO Walter Rosebrough on Q2 2021 Results - Earnings Call Transcript

Zacks Investment Research - 2 months ago

STERIS' (STE) second-quarter fiscal 2021 results reflect strong performance by the Life Sciences and the Applied Sterilization Technologies segments despite the coronavirus-led economic crisis.

Zacks Investment Research - 2 months ago

Steris (STE) delivered earnings and revenue surprises of 19.35% and 7.23%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire - 2 months ago

DUBLIN, IRELAND , Nov. 02, 2020 (GLOBE NEWSWIRE) --  STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2021 second quarter ended September 30,...

Zacks Investment Research - 2 months ago

Several medical product stocks have come up with bullish earnings reports so far this reporting cycle. Let's see how STE, HSIC, PACB, INSP are poised ahead of their announcements.

Other stocks mentioned: HSIC, INSP, PACB
Zacks Investment Research - 2 months ago

Within Life Sciences, STERIS (STE) might have registered benefit from pharma customers on growing vaccines and biologics businesses in Q2.

The Motley Fool - 2 months ago

COVID-19 has heightened the demand for companies that specialize in infection control.

Other stocks mentioned: CMD, JNJ
Zacks Investment Research - 2 months ago

Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire - 3 months ago

DUBLIN, IRELAND, Oct. 20, 2020 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2021 second quar...

Zacks Investment Research - 3 months ago

Steris (STE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Market Watch - 3 months ago

Steris PLC STE, +1.18% said Tuesday it has agreed to acquire Key Surgical, a portfolio company of Water Street Healthcare Partners LLC for $850 million. Dublin, Ireland-based Steris expects th...

GlobeNewsWire - 3 months ago

DUBLIN, IRELAND, Oct. 06, 2020 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that the Company has signed a definitive agreement to purchase Key Surgica...

Invezz - 3 months ago

The U.S. presidential election is less than 50 days away and the health care sector could prove to be the most impacted. On Monday, Chantico Global CEO Gina Sanchez laid out on CNBC’s “Trading...

Other stocks mentioned: TNDM
Zacks Investment Research - 4 months ago

STERIS (STE) is optimistic about maintaining growth momentum on broader product and service portfolio along with strength in its Life Sciences business.

Zacks Investment Research - 4 months ago

Steris (STE) reported earnings 30 days ago. What's next for the stock?

Seeking Alpha - 5 months ago

5 Dividend Increases For The Week Of August 23rd With 1 Dividend King

Other stocks mentioned: BMI, DOV, RBA, SMG
Seeking Alpha - 5 months ago

STERIS plc (STE) CEO Walter Rosebrough on Q1 2021 Results - Earnings Call Transcript

Zacks Investment Research - 5 months ago

STERIS' (STE) first-quarter fiscal 2021 results reflect strong performance by the Life Sciences segment despite the coronavirus-led economic crisis.

Zacks Investment Research - 5 months ago

Steris (STE) delivered earnings and revenue surprises of 35.05% and 4.55%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire - 5 months ago

•         First quarter revenue declines low-single digits due to reduction in deferrable procedures •         First quarter net income grows low-single digits driven by margin expansion •...

Zacks Investment Research - 5 months ago

STERIS (STE) registers declines in Healthcare Products with neutral performance in Life Science and AST in April, which is likely to have impacted Q1 earnings.

GlobeNewsWire - 6 months ago

DUBLIN, IRELAND, July 22, 2020 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2021 first qua...

Zacks Investment Research - 7 months ago

As a major landmark for STERIS (STE), in fiscal 2020, the company joined the coveted S&P 500 Index.

The Motley Fool - 7 months ago

Steris and Fortive are on the rise, thanks in part to their medical devices used to decontaminate N95 or N95-equivalent respirators.

Other stocks mentioned: FTV
GlobeNewsWire - 7 months ago

DUBLIN, IRELAND, May 26, 2020 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has issued another Emerg...

Zacks Investment Research - 8 months ago

STERIS' (STE) fourth-quarter fiscal 2020 results reflect strong segmental performance despite the coronavirus-led economic crisis.

Seeking Alpha - 8 months ago

STERIS' (STE) CEO Walt Rosebrough on Q4 2020 Results - Earnings Call Transcript

Zacks Investment Research - 8 months ago

Steris (STE) delivered earnings and revenue surprises of 4.46% and 4.39%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire - 8 months ago

DUBLIN, IRELAND, May 13, 2020 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2020 fourth quarter ended March 31, 2020...

Zacks Investment Research - 8 months ago

Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 8 months ago

Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire - 9 months ago

DUBLIN, IRELAND, April 10, 2020 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergenc...

Zacks Investment Research - 9 months ago

Investors continue to be optimistic about STERIS (STE) on its strong segmental growth in the third quarter of 2020.

Zacks Investment Research - 9 months ago

Despite coronovirus upsurge, a handful of S&P 500 stocks rallied last week. Some of them carry a favorable Zacks Rank with strong potential for future growth.

Other stocks mentioned: CPB, EQIX, MKTX, REGN
Zacks Investment Research - 9 months ago

STERIS (STE) continues to register stellar organic growth across all four operating segments.

Zacks Investment Research - 10 months ago

Studies have shown that a majority of stocks had seen acceleration in earnings before a rally in stock price.

Other stocks mentioned: ENVA, MDT
Investors Business Daily - 10 months ago

Steris shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 76 to 82. The post Steris Meets 80-Plus Relative Strength Rating Benchmark appeared first on ...

Zacks Investment Research - 10 months ago

Steris (STE) reported earnings 30 days ago. What's next for the stock?

About STE

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including... [Read more...]

Industry
Medical Instruments & Supplies
IPO Date
Jun 1, 1992
CEO
Walter Rosebrough
Employees
13,000
Stock Exchange
NYSE
Ticker Symbol
STE
Full Company Profile

Financial Performance

In 2019, Steris's revenue was $3.03 billion, an increase of 8.94% compared to the previous year's $2.78 billion. Earnings were $407.61 million, an increase of 34.06%.

Financial Statements

Analyst Forecasts

According to 7 analysts, the average rating for Steris stock is "Buy." The 12-month stock price forecast is 221.33, which is an increase of 17.25% from the latest price.

Price Target
$221.33
(17.25% upside)
Analyst Consensus: Buy